Literature DB >> 17080994

Sulfated meroterpenoids from the Brazilian sponge Callyspongia sp. are inhibitors of the antileishmaniasis target adenosine phosphoribosyl transferase.

Christopher A Gray1, Simone P de Lira, Marcio Silva, Eli F Pimenta, Otavio H Thiemann, Glaucius Oliva, Eduardo Hajdu, Raymond J Andersen, Roberto G S Berlinck.   

Abstract

Three new disulfated meroterpenoids, ilhabelanol (1), ilhabrene (2), and isoakaterpin (3), have been isolated from extracts of the Brazilian marine sponge Callyspongia sp. Isoakaterpin (3) inhibits Leishmania spp. adenosine phosphoribosyl transferase with an IC50 of 1.05 microM. The structures of 1, 2, and 3 were elucidated by analysis of one- and two-dimensional NMR data. Ilhabelanol (1) and ilhabrene (2) both have unprecedented meroterpenoid carbon skeletons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17080994     DOI: 10.1021/jo060295k

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  9 in total

1.  Isolation, Derivative Synthesis, and Structure-Activity Relationships of Antiparasitic Bromopyrrole Alkaloids from the Marine Sponge Tedania brasiliensis.

Authors:  Lizbeth L L Parra; Ariane F Bertonha; Ivan R M Severo; Anna C C Aguiar; Guilherme E de Souza; Glaucius Oliva; Rafael V C Guido; Nathalia Grazzia; Tábata R Costa; Danilo C Miguel; Fernanda R Gadelha; Antonio G Ferreira; Eduardo Hajdu; Daniel Romo; Roberto G S Berlinck
Journal:  J Nat Prod       Date:  2018-01-03       Impact factor: 4.050

Review 2.  Biological activities of meroterpenoids isolated from different sources.

Authors:  Neeraj Kumar Fuloria; Radhika K Raheja; Kaushal H Shah; Manisha J Oza; Yogesh A Kulkarni; Vetriselvan Subramaniyan; Mahendran Sekar; Shivkanya Fuloria
Journal:  Front Pharmacol       Date:  2022-09-19       Impact factor: 5.988

Review 3.  Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Mark T Hamann
Journal:  Biochim Biophys Acta       Date:  2009-03-19

4.  Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensis.

Authors:  Deivid Costa Soares; Teresa C Calegari-Silva; Ulisses G Lopes; Valéria L Teixeira; Izabel C N de Palmer Paixão; Claudio Cirne-Santos; Dumith Chequer Bou-Habib; Elvira M Saraiva
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

5.  Ethnopharmacological survey among migrants living in the Southeast Atlantic Forest of Diadema, São Paulo, Brazil.

Authors:  Daniel Garcia; Marcus Vinicius Domingues; Eliana Rodrigues
Journal:  J Ethnobiol Ethnomed       Date:  2010-10-29       Impact factor: 2.733

Review 6.  Marine Sponges and Bacteria as Challenging Sources of Enzyme Inhibitors for Pharmacological Applications.

Authors:  Nadia Ruocco; Susan Costantini; Flora Palumbo; Maria Costantini
Journal:  Mar Drugs       Date:  2017-06-12       Impact factor: 5.118

7.  A new 1,4-diazepine from South China Sea marine sponge Callyspongia species.

Authors:  Ri-Ming Huang; Wei Ma; Jun-De Dong; Xue-Feng Zhou; Tunhai Xu; Kyung Jin Lee; Xianwen Yang; Shi-Hai Xu; Yonghong Liu
Journal:  Molecules       Date:  2010-02-10       Impact factor: 4.411

Review 8.  Meroterpenes from marine invertebrates: structures, occurrence, and ecological implications.

Authors:  Marialuisa Menna; Concetta Imperatore; Filomena D'Aniello; Anna Aiello
Journal:  Mar Drugs       Date:  2013-05-17       Impact factor: 5.118

Review 9.  Metabolities from Marine Sponges of the Genus Callyspongia: Occurrence, Biological Activity, and NMR Data.

Authors:  Lucas Hilário Nogueira de Sousa; Rusceli Diego de Araújo; Déborah Sousa-Fontoura; Fabrício Gava Menezes; Renata Mendonça Araújo
Journal:  Mar Drugs       Date:  2021-11-26       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.